Tendon injuries are a significant cause of morbidity and reduced quality of life, affecting millions of people worldwide. Current treatment options often fall short in achieving optimal functional recovery, highlighting the need for innovative approaches. In recent years, emerging technologies in regenerative medicine have shown great promise in addressing the challenges associated with tendon injuries. Among these advancements, decellularized placental biomaterials have garnered significant attention for their remarkable potential in promoting tendon healing and protection. This article delves into the study presented by Celularity Inc. at the Orthopedic Research Society (ORS) Tendon Conference, shedding light on the exciting prospects offered by decellularized placental biomaterials.
Celularity’s Research Breakthrough:Celularity Inc. a renowned regenerative medicine company, announced the acceptance of their abstract
Comments